MNNGF (Baijin Life Science Holdings) Construction In Progress: $1.41 Mil (As of Sep. 2025)


MNNGF Baijin Life Science Holdings Ltd MNNGF
34 GF Score
Price $0.08
GF Value $0.04
! 6 Warning Signs
View Full Analysis

What is Baijin Life Science Holdings Construction In Progress?

Baijin Life Science Holdings MNNGF 34 Construction In Progress is $1.41 Mil as of Sep. 2025. GuruFocus rates MNNGF with a GF Score™ of 34/100 and a GF Value™ of $0.04. The stock has 6 warning signs investors should review.

Baijin Life Science Holdings's quarterly construction in progress stayed the same from Sep. 2024 ($0.00 Mil) to Mar. 2025 ($0.00 Mil) but then increased from Mar. 2025 ($0.00 Mil) to Sep. 2025 ($1.41 Mil).

Baijin Life Science Holdings Construction In Progress Historical Data

* Premium members only.

The historical data trend for Baijin Life Science Holdings's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baijin Life Science Holdings Construction In Progress Chart

Baijin Life Science Holdings Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Baijin Life Science Holdings Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 1.41
MNNGF
34GF Score
Baijin Life Science Holdings Ltd MNNGF
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baijin Life Science Holdings Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $1.41 Mil mean?
Baijin Life Science Holdings (MNNGF) has a Construction In Progress of $1.41 Mil as of Sep. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Baijin Life Science Holdings and its competitors.
Is Baijin Life Science Holdings' Construction In Progress too high?
Baijin Life Science Holdings' current Construction In Progress is $1.41 Mil. Overall, Baijin Life Science Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Construction In Progress compare to TPR?
Baijin Life Science Holdings' Construction In Progress of $1.41 Mil can be compared against companies in the Retail - Cyclical industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Retail - Cyclical company?
A good Construction In Progress depends on the Retail - Cyclical industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Baijin Life Science Holdings and its competitors. Baijin Life Science Holdings's current Construction In Progress is $1.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Construction In Progress of $1.41 Mil. The stock's GF Value™ is $0.04, compared to a current price of $0.08 — trading 87.5% above its estimated fair value. The current Construction In Progress is $1.41 Mil. Baijin Life Science Holdings' overall GF Score™ is 34/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Construction In Progress is $1.41 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?

Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued. The current stock price of $0.08 is trading 87.5% above its estimated GF Value™ of $0.04.

Key valuation signals for MNNGF:

  • Construction In Progress: $1.41 Mil
  • GF Value™: $0.04 vs. price of $0.08 (87.5% above fair value)
  • GF Score™: 34/100 with 6 warning signs

No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Baijin Life Science Holdings Business Description

Other Exchanges 01466:Hong Kong
Address 66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
34GF Score

Get the complete analysis for MNNGF

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.04
GF Value